Janice asks the question: 'Calcium Supplements And Pain Medication?' — -- Question: Hi. I'm Janice. I'm of an age to need calcium supplements, but I'm on Neurontin -- which is made less ...

Since Neurontin is now being handed out like Butterfingers at Halloween it is fair to ask whether there is evidence that it works. Fortunately, Drs. Christopher Goodman and Allan S. Brett ask just ...

Neurontin is often used off-label as a treatment for migraine headaches, and this, too, is controversial. Among the 12 reports is one by Dr. Douglas McCrory, ...

We just came across another drug education project that's getting a boost from the 2004 settlement over off-label marketing of Pfizer's pain and epilepsy medicine Neurontin. Oregon's attorney ...

Neurontin works, but less well than Advil and Tylenol. If I'm in post-op in pain and someone brings me a Neurontin pill I will somehow summon up the energy to throw it into the hall, and maybe even ...

Neurontin NPR's Snigdha Prakash reports on a lawsuit in Boston that is revealing how companies promote prescription drugs. The case was filed by a former salesman for Parke Davis, who charged that ...

Here's a depressing exchange in the litigation on Pfizer's anti-seizure med, Neurontin. It's between the doctor of Susan Bulger, who killed herself after taking the pill. Her family claims Pfizer ...

Neurontin's sales soared from $97.5 million in 1995 to nearly $2.7 billion in 2003. In a written statement, Pfizer said the illegal practices took place before Pfizer acquired Warner-Lambert in ...

Thanks to a big settlement back in 2004 over off-label marketing epilepsy drug Neurontin, there's a new source of information about prescription drugs that isn't funded directly by Big Pharma. Run ...

Pfizer (PFE)'s marketing team created a PowerPoint slide which depicted its anti-seizure drug Neurontin as a witch's brew (pictured) and its marketing unit as a magic cauldron -- an apparent ...

Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the ...

Neurontin Lawsuit A whistleblower lawsuit alleges that the drug company Parke-Davis devised an illegal strategy to market its anti-epilepsy drug Neurontin for unapproved uses.